Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2025-12-25 @ 2:31 AM
NCT ID:
NCT02219334
Eligibility Criteria:
Inclusion Criteria:
* patients above the age of 2 months and post-gestational age to 44 weeks and less than or equal to 2 years with signs and symptoms of bronchiolitis
* clinical respiratory score (CRS) of less than or equal to 4
* principle diagnosis of bronchiolitis (International Classification of Diseases-9: 466, 466.11 and 466.19)
* Patient admitted to the Pediatric Hospitalist Medicine (PHM) group
* Patient with associated hypoxemia and/or respiratory distress requiring low flow O2 nasal cannula (NC) management (2L/min or less)
Exclusion Criteria:
* age less than 2 months
* age less than post-gestational age 44 weeks
* CRS greater than 4
* associated hypoxia
* already using NoseFrida at home
* chronic lung disease
* oro-facial abnormalities
* cardiac abnormalities
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Months
Maximum Age:
2 Years
Study:
NCT02219334
Study Brief:
Protocol Section:
NCT02219334